Solaris Energy Infrastructure, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Solaris Energy Infrastructure, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $622.21M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $313.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $292.95M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $320.01M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $159.19M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $102.98M | Mar 9, 2023 |
| FY2017 | Dec 31, 2017 | $25.20M | Mar 6, 2018 |
| FY2017 | Sep 30, 2017 | $18.48M | Mar 6, 2018 |
| FY2017 | Jun 30, 2017 | $13.39M | Mar 6, 2018 |
| FY2017 | Mar 31, 2017 | $10.32M | Mar 6, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $300.00M | Mar 9, 2023 |
| FY2022 | Dec 31, 2021 | $145.72M | Mar 9, 2023 |
| FY2020 | Dec 31, 2020 | $25.28M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $20.53M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $9.34M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $47.83M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $62.86M | Feb 23, 2021 |
| FY2020 | Sep 30, 2019 | $59.60M | Feb 23, 2021 |
| FY2020 | Jun 30, 2019 | $64.10M | Feb 23, 2021 |
| FY2020 | Mar 31, 2019 | $55.12M | Feb 23, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $15.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $24.34M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $21.16M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | ($868.0K) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($1.44M) | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | ($3.28M) | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | ($5.54M) | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | ($19.08M) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $15.02M | Feb 23, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.39M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $52.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $49.90M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $41.80M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | ($387.0K) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($3.42M) | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | ($6.41M) | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | ($10.73M) | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | ($39.34M) | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $30.09M | Feb 23, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $0 | Feb 23, 2021 |
| FY2020 | Dec 31, 2018 | $0 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $210.0K | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $476.0K | Jul 26, 2019 |
| FY2017 | Dec 31, 2015 | $141.0K | Mar 6, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.66M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $35.62M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $26.95M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $23.07M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $19.26M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $16.48M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $18.59M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $16.76M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $14.29M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $2.10M | Jul 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $209.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $59.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $89.35M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $68.00M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $16.47M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $43.85M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $114.87M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $116.37M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $26.73M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $4.52M | Jul 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $646.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $188.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $64.39M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $81.41M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $19.64M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $4.66M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $34.85M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $161.08M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $93.91M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $10.90M | Jul 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $468.30M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $462.58M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $406.22M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $411.90M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $505.07M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $458.61M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $299.74M | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $77.24M | Mar 6, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.32B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $463.73M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $152.72M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $145.45M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $108.35M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $96.42M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $95.41M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $117.73M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $45.50M | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $5.89M | Mar 6, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $564.34M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $355.62M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $205.98M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $215.72M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $203.15M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $201.25M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $263.85M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $198.45M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $113.39M | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $71.35M | Mar 6, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $103.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $13.00M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $13.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $13.00M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $13.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $17.24M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $17.24M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $17.24M | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $13.00M | Mar 6, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.07M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $17.66M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $17.31M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $12.85M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $5.93M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $20.55M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $74.22M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $35.51M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($4.17M) | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $2.08M | Mar 6, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.32M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $114.26M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $5.83M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $8.84M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $36.50M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $60.37M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $66.88M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $25.06M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $63.42M | Jul 26, 2019 |
| FY2017 | Dec 31, 2016 | $3.57M | Mar 6, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $184.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $315.70M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $30.00M | Mar 5, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Jul 26, 2019 |
| FY2018 | Sep 30, 2017 | 0 | Jul 26, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Jul 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Jul 26, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Jul 26, 2019 |
| FY2018 | Sep 30, 2017 | 0 | Jul 26, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Jul 26, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $14.07M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $13.80M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $13.41M | Feb 27, 2024 |
| FY2021 | Dec 31, 2020 | $12.39M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $12.76M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.75M | Feb 19, 2020 |
| FY2018 | Dec 17, 2018 | $2.75M | Jul 26, 2019 |